Login
← Go Back
Alivus Life Sciences
ALIVUS · Pharma > Pharmaceuticals & Drugs · Chairman: Glenn Saldanha · MD: Yasir Rawjee · Listing date: Aug. 7, 2021 · Employees: 1537 · Mumbai · http://www.glenmarklifesciences.com
Stock Price vs Company Growth
1d
1.5%
1w
4.0%
1m
0.1%
3m
16.7%
6m
38.5%
1y
44.6%
5y
17.8%
all
15.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,345 1.5%
1,084
1,490
Company Overview
Sales
2,590 Cr
Growth: 6.8%
Profit after Tax
603 Cr
Growth: 6.8%
Mid Cap
16,510 Cr
P/E: 27.4x
Industry P/E: 35.1x
Fundamentals
Sales (Cr) ₹ 2,590
Growth 6.8%
EBITDA 32.3%
P/S 6.4x
Dividend 0.5%
P/E 27.4x
Book Value ₹ 284
PEG Ratio 4.1x
ROE 18.4%
P/B 4.8x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is in the business of making high-quality drugs by unlocking the possibilities of science.Awards, accreditations and recognitions2015: Ankleshwar plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Dahej plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Ankleshwar plant received BS OHSAS 18001:2017 certifying the management system of the manufacturing facility.
Belongs to (14 Indices) view more
Investors (7)
societe....
santhosh...
nirma
Followers (2)
atharav
varsha96